USANA Health Sciences (NYSE:USNA) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS

USANA Health Sciences (NYSE:USNA) posted its quarterly earnings results on Tuesday. The company reported $1.36 EPS for the quarter, beating the consensus estimate of $1.30 by $0.06, MarketWatch Earnings reports. USANA Health Sciences had a return on equity of 33.65% and a net margin of 11.09%. During the same period in the previous year, the company posted $1.44 earnings per share. USANA Health Sciences updated its FY 2021 guidance to $5.800-$6.000 EPS.

Shares of NYSE USNA traded down $7.25 during trading on Wednesday, reaching $92.48. The company had a trading volume of 118,238 shares, compared to its average volume of 87,855. USANA Health Sciences has a twelve month low of $73.00 and a twelve month high of $107.85. The stock has a market capitalization of $1.85 billion, a PE ratio of 14.16 and a beta of 0.85. The stock has a 50-day moving average price of $94.61 and a two-hundred day moving average price of $98.21.

Several analysts have recently commented on USNA shares. Zacks Investment Research raised USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Wednesday, September 29th. Tigress Financial reaffirmed a “buy” rating and set a $122.00 price objective on shares of USANA Health Sciences in a report on Friday, October 8th.

In other news, Director John Turman Fleming sold 300 shares of USANA Health Sciences stock in a transaction on Monday, August 30th. The stock was sold at an average price of $97.26, for a total value of $29,178.00. Following the completion of the sale, the director now owns 851 shares of the company’s stock, valued at $82,768.26. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Robert A. Sinnott sold 1,648 shares of USANA Health Sciences stock in a transaction on Monday, August 16th. The shares were sold at an average price of $95.04, for a total value of $156,625.92. Following the completion of the sale, the insider now directly owns 1,648 shares of the company’s stock, valued at approximately $156,625.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 3,435 shares of company stock valued at $331,837. Insiders own 0.21% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.

Featured Article: What is a capital gain?

Earnings History for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.